• Publish Your article
  • Editorial Policy
  • Contact
  • Advertise
Sunday, September 14, 2025
No Result
View All Result
UK Herald
  • Home
  • Politics
  • Business
  • Entertainment
    • All
    • Sports
    England rugby stadium Twickenham given new name after more than 100 years in shock new deal

    England rugby stadium Twickenham given new name after more than 100 years in shock new deal

    Peter Morgan dead at 65: Former Wales and Lions rugby star who became a politician passes away as club pays tribute

    Peter Morgan dead at 65: Former Wales and Lions rugby star who became a politician passes away as club pays tribute

    Horse racing tips: Unexposed Group 1 contender can stun the big guns at 14-1

    Horse racing tips: Unexposed Group 1 contender can stun the big guns at 14-1

    Woman ‘raped seven times by two French rugby stars who left her riddled with bite marks & with horror injuries’

    Woman ‘raped seven times by two French rugby stars who left her riddled with bite marks & with horror injuries’

    Horse racing tips: Gary Moore’s charge can gain revenge after falling last time out

    Horse racing tips: Gary Moore’s charge can gain revenge after falling last time out

    Ian Buckett dead at 56: Former Wales rugby star who was ‘admired and feared equally’ dies as tributes pour in

    Ian Buckett dead at 56: Former Wales rugby star who was ‘admired and feared equally’ dies as tributes pour in

    Horse racing tips: Bash the bookies with these longshots including 9-1 fancy

    Horse racing tips: Bash the bookies with these longshots including 9-1 fancy

    Shayne Philpott dead at 58 – New Zealand All Blacks rugby legend dies after suffering ‘medical event’

    Shayne Philpott dead at 58 – New Zealand All Blacks rugby legend dies after suffering ‘medical event’

    Horse racing tips: This 7-1 chance appears to have been laid out for race he won last year

    Horse racing tips: This 7-1 chance appears to have been laid out for race he won last year

  • Lifestyle
    • All
    • Fashion
    • food
    • Health
    • Travel
    I feel like a stranger in the UK after 21 years abroad

    I feel like a stranger in the UK after 21 years abroad

    Is it safe to travel to Poland right now? Latest advice after Russian drone attack

    Is it safe to travel to Poland right now? Latest advice after Russian drone attack

    I stayed at the new London hotel with immunity-boosting IV drips and a free photobooth

    I stayed at the new London hotel with immunity-boosting IV drips and a free photobooth

    Europe’s 20 cheapest beach towns revealed – golden sand and £33 flights

    Europe’s 20 cheapest beach towns revealed – golden sand and £33 flights

    Discover Africa’s hidden gem for winter sun – luxury, culture and no jetlag

    Discover Africa’s hidden gem for winter sun – luxury, culture and no jetlag

    Little-visited Caribbean island is getting new £292,000,000 airport and first-ever direct UK flights

    Little-visited Caribbean island is getting new £292,000,000 airport and first-ever direct UK flights

    Gigantic £777,577,500 cruise ship with record-breaking water park to launch from UK

    Gigantic £777,577,500 cruise ship with record-breaking water park to launch from UK

    British Airways First Lounge at Heathrow Airport review: ‘So relaxing, I missed the final boarding call’

    British Airways First Lounge at Heathrow Airport review: ‘So relaxing, I missed the final boarding call’

    The cheapest Spanish holiday destinations revealed – from £13 flights to £31 hotels

    The cheapest Spanish holiday destinations revealed – from £13 flights to £31 hotels

    I followed a dusty path in Ibiza and found the ‘White Isle’s’ most iconic hotel

    I followed a dusty path in Ibiza and found the ‘White Isle’s’ most iconic hotel

    Trending Tags

    • Golden Globes
    • Mr. Robot
    • MotoGP 2017
    • Climate Change
    • Flat Earth
  • Health
  • Opinion
  • Science
  • Tech
  • Crypto
  • Travel
  • Real Estate
  • Sports
  • More
    • Press Release
UK Herald
No Result
View All Result

NOVEL CARBOHYDRATE ANTIVIRAL DRUG CANDIDATE ACTS THROUGH GALECTIN INHIBITION TO BLOCK SARS-COV-2 CORONAVIRUS

by Justin Marsh
August 21, 2022
0
0
SHARES
Share on FacebookShare on TwitterReddit

BIOXYTRAN, INC. (Symbol: BIXT) (the “Company”), a clinical stage biotechnology company developing oral drugs to treat COVID-19 and other viral causing diseases announced today that the journal of International Journal of Health Sciences1 released a peer-reviewed article, “Carbohydrate ProLectin-M, a Galectin-3 Antagonist, Blocks SARS-CoV-2 Activity”, that supports ProLectin-M’s in vitro Mode of Action and the initial clinical data results reported in a previous article, referred to below. ProLectin-M is the Company’s leading drug molecule in its pipeline to treat viral infections.

The journal article begins to outline and further define the mechanism of action (MOA) behind the oral galectin inhibitor Prolectin-M.  The article confirms and further expands on the preliminary clinical data results from Bioxytran’s first peer-reviewed journal article in the Journal of Vaccines & Vaccination2, “Galectin Antagonist use in Mild Cases of SARS-CoV-2: Pilot Feasibility Randomised, Open Label, Controlled Trial”, whereby human clinical trial results showed elimination of viral load to undetectable levels within a few days.  The analytical tests within the scope of this most recent journal article utilize some of the most rigorously binding tests between a Lectin class of protein and carbohydrates.

1)     https://sciencescholar.us/journal/index.php/ijhs/article/view/10033

2)     https://www.walshmedicalmedia.com/open-access/galectin-antagonist-use-in-mild-cases-of-sarscov2-pilot-feasibility-randomised-open-label-controlled-trial-61087.html

About Bioxytran, Inc.

Bioxytran, Inc. is a clinical stage biotechnology company developing novel therapies targeting the treatment of significant unmet medical needs in virology, degenerative disease, and hypoxia. The leading drug candidate, Prolectin-M, is a new class of antiviral drug designed to antagonize galectins implicated in inflammatory, fibrotic, and malignant diseases and bind to the conserved region of the spike protein commonly known as the galectin fold.  Bioxytran’s other development programs are for pulmonary fibrosis and stroke treatment.   More information can be found at www.bioxytraninc.com

About Galectins

Galectins are carbohydrate-binding proteins that are involved in many physiological functions, such as inflammation, immune responses, cell migration, autophagy, and signaling. They are also linked to diseases such as fibrosis, cancer and heart disease.

About Lectins

Galectins are a class of specific lectins.  Lectins are a special class of proteins widely distributed in nature, which selectively recognize and reversibly bind to carbohydrates and glycoconjugates through their binding sites. These proteins, which can be detected through hemagglutination assays, interact with different carbohydrates present in cell and viral surfaces.

About ProLectin-M

ProLectin-M is an orally administered experimental new drug candidate that targets the Carbohydrate Binding Domain portion on the SARS-CoV-2, coronavirus.  ProLectin-M is expected to interfere with the binding of the virus to the cell and thereby prevent viral entry into cells.  Preclinical in-vitro and in-vivo preliminary data shows that ProLectin-M is non-toxic for humans.  ProLectin-M was used in an open label, randomized, controlled clinical feasibility study in COVID-19 patients with mild-to-moderate COVID-19 disease.

Investor Relations:
Michael Sheikh
509-991-0245
[email protected]

Forward-Looking Statements

This press release includes forward-looking statements as defined under federal law, including those related to the performance of technology described in this press release. These forward-looking statements are generally identified by the words “believe,” “expect,” “anticipate,” “estimate,” “intend,” “plan,” and similar expressions, although not all forward-looking statements contain these identifying words. Such statements are subject to significant risks, assumptions and uncertainties. Known material factors that could cause Bioxytran’s actual results to differ materially from the results contemplated by such forward-looking statements are described in the forward-looking statements and risk factors in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2021 and those risk factors set forth from time-to-time in other filings with the Securities and Exchange Commission. Bioxytran undertakes no obligation to correct or update any forward-looking statement, whether as a result of new information, future events, or otherwise, except to the extent required under federal securities laws.

Media Contact
Company Name: Bioxytran, Inc.
Contact Person: Michael Sheikh
Email: Send Email
Country: United Kingdom
Website: www.bioxytraninc.com

Related Posts

The UK’s Decision Velocity Gap—and How Platform-Native ERP Closes It

by Clara White
September 13, 2025
0

Most firms don’t lack analytics; they lack speed. Platform-native ERP on Salesforce turns signals into actions faster, with control and auditability. Why UK Digital Investments Still Leave Surprises Across the UK, leaders...

From Bus to Business: Essex Soft Play Venture Revolutionises the Kids Party Scene

by Amina
August 28, 2025
0

A local Essex business is driving innovation in children’s party entertainment — quite literally. The Essex Soft Play Bus has transformed an ordinary double-decker into a fully equipped mobile soft play centre,...

Generative AI and the Future of Front-End Engineering: Ethical and Practical Implications

by Justin Marsh
August 23, 2025
0

Introduction Generative Artificial Intelligence (AI) is rapidly transforming how we design and build the web’s user interfaces. As a front-end engineer driving data-driven features at Atarim, I have witnessed firsthand how tools...

Tired of Complicated Switching? Why CheckMyBills Might Be the Solution

Tired of Complicated Switching? Why CheckMyBills Might Be the Solution

by Clara White
August 16, 2025
0

If switching energy suppliers feels like filling in a small novel, you’re not alone. Lengthy forms, required accounts, confusing tariff names and a fear of losing supply put many people off switching...

Global First! DEEP Robotics Robot Dogs Go Deep into Hoh Xil to Collaborate in Protecting Tibetan Antelopes

by Justin Marsh
August 15, 2025
0

Recently, at Zhuonai Lake deep in the uninhabited area of Hoh Xil, which is above 4,800 meters above sea level, a "robotic Tibetan antelope" made based on DEEP Robotics X30 quadruped robot...

Coinplex — The Power of Technology and Responsibility Together

by Justin Marsh
August 6, 2025
0

In recent years, Coinplex has earned the trust of tens of thousands of users worldwide, becoming one of the leading digital finance platforms. It has also played an increasingly impactful role in...

Next Post
Stellar Story Custom Birth Chart Jewelry Creates Cosmic Energy

Stellar Story Custom Birth Chart Jewelry Creates Cosmic Energy

Popular News

Week-in-Review: Mandelson scandal exposes fragility of Starmer’s standing

Week-in-Review: Mandelson scandal exposes fragility of Starmer’s standing

September 14, 2025
News diary 15-21 September: Trump visits UK, interest rate decision, sentencing of Constance Marten and Mark Gordon

News diary 15-21 September: Trump visits UK, interest rate decision, sentencing of Constance Marten and Mark Gordon

September 14, 2025
MCLAREN 750S JC96 Edition is created special for japan

MCLAREN 750S JC96 Edition is created special for japan

September 13, 2025
I feel like a stranger in the UK after 21 years abroad

I feel like a stranger in the UK after 21 years abroad

September 13, 2025
Gavin Williamson: ‘Appointing Mandelson was a grave error – Starmer must be held accountable’

Gavin Williamson: ‘Appointing Mandelson was a grave error – Starmer must be held accountable’

September 12, 2025
More growth, fewer boats: Starmer’s reshuffle signals determination to deliver

More growth, fewer boats: Starmer’s reshuffle signals determination to deliver

September 10, 2025
30M Drivers Could Be Given Car-Finance Compensation Worth £ 18bn, MPS Told

30M Drivers Could Be Given Car-Finance Compensation Worth £ 18bn, MPS Told

September 10, 2025
UK Herald

All Rights Reserved © UK HERALD - The Voice of UK

Important Links

  • Publish Your article
  • Editorial Policy
  • Contact
  • Advertise

...

No Result
View All Result
  • Home
  • Politics
  • UK News
  • Business
  • Science
  • National
  • Entertainment
  • Gaming
  • Sports
  • Fashion
  • Lifestyle
  • Travel
  • Health
  • Food

All Rights Reserved © UK HERALD - The Voice of UK